Dr. Onyike is a specialist in neuropsychiatry. He focuses on the diagnosis and care of neurodegenerative diseases that develop in midlife or earlier. These include frontotemporal dementias, young-onset Alzheimer diseases, prion diseases, leukodystrophy and other atypical conditions that cause cognitive and behavioral impairments and dementia. He is also engaged in research focused on the epidemiology and treatment of frontotemporal dementias, Alzheimer disease, Lewy body disease, spinocerebellar ataxias, and other neurodegenerative disorders.
Dr. Onyike has advised national and international research agencies, and philanthropic organizations, including the NIH, FDA, MRC-UK, and others. He serves on the Medical Advisory Council of the Association for Frontotemporal Degeneration, and the Scientific Advisory Boards of the FTD Disorders Registry and the Tau Consortium. He serves on the Alzheimer’s Association Best Clinical Practices Guidelines Work Group, and has participated in NIA/NINDS Alzheimer’s Disease and Related Dementias workshop committees. He is a founding member of the International Society for Frontotemporal Dementias, and a member of the Executive Committee.